Aviva’s NEVRO CORP. NVRO Stock Holding History

Aviva’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,598	Closed	-$1.2M	–	990
2021 Q1	$1.2M	Sell	8,598 -122	-1%	-$19.9K	0.01%	854
2020 Q4	$1.51M	Sell	8,720 -7,070	-45%	-$1.15M	0.01%	760
2020 Q3	$2.2M	Sell	15,790 -3,548	-18%	-$474K	0.01%	751
2020 Q2	$2.31M	Buy	+19,338	New	+$2.29M	0.01%	675

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aviva's NVRO Position: Q2 2021 in Review

Aviva sold out of NEVRO CORP. (NVRO) in Q2 2021, closing a stake of 8,598 shares — an estimated $1.2M sold.

Aviva first reported a position in NVRO in Q2 2020 and held it in 4 quarters. The position peaked at $2.31M in Q2 2020. 207 funds tracked by Wall St. Rank hold NVRO as of Q2 2021.

Aviva reported no remaining NEVRO CORP. position as of Q2 2021 after selling out during the quarter.
Aviva sold 8,598 NEVRO CORP. shares in Q2 2021, an estimated $1.2M.
Aviva first reported a position in NEVRO CORP. in Q2 2020 and held it in 4 quarters.
Aviva's NEVRO CORP. position peaked at $2.31M in Q2 2020.
207 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.